Pulmonary surfactant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza A virus

FEBS Lett. 1993 May 10;322(2):115-9. doi: 10.1016/0014-5793(93)81549-f.


The pathogenicities of influenza viruses and paramyxoviruses have been proposed to be primarily determined by a host cell protease(s) that activates viral infectivity by proteolytic cleavage of the envelope glycoproteins. We recently isolated a trypsin-type endoprotease, named tryptase Clara, from rat bronchial and bronchiolar epithelial Clara cells, which is secreted into the airway lumen and activates Sendai virus and influenza A virus proteolytically. We report here that surfactant in the bronchial fluid inhibited tryptase Clara specifically, having a Ki value of 0.13 microM, and inhibited the proteolytic activations by tryptase Clara in vitro and in organ cultures of rat lung. Intranasal infection of rats with Sendai virus was shown to stimulate secretion of tryptase Clara without changing the amount of surfactant in the bronchial lumen, resulting in a preferable condition for proteolytic viral activation and multiplication.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Bronchoalveolar Lavage Fluid
  • Influenza A virus / growth & development
  • Lung / enzymology
  • Lung / microbiology
  • Molecular Sequence Data
  • Organ Culture Techniques
  • Parainfluenza Virus 1, Human / growth & development
  • Pulmonary Surfactants / physiology*
  • Rats
  • Serine Endopeptidases / metabolism*
  • Tryptases
  • Virus Activation / physiology*


  • Pulmonary Surfactants
  • Serine Endopeptidases
  • tryptase Clara
  • Tryptases